Your browser doesn't support javascript.
loading
The Atlas of Inflammation Resolution (AIR).
Serhan, Charles N; Gupta, Shailendra K; Perretti, Mauro; Godson, Catherine; Brennan, Eoin; Li, Yongsheng; Soehnlein, Oliver; Shimizu, Takao; Werz, Oliver; Chiurchiù, Valerio; Azzi, Angelo; Dubourdeau, Marc; Gupta, Suchi Smita; Schopohl, Patrick; Hoch, Matti; Gjorgevikj, Dragana; Khan, Faiz M; Brauer, David; Tripathi, Anurag; Cesnulevicius, Konstantin; Lescheid, David; Schultz, Myron; Särndahl, Eva; Repsilber, Dirk; Kruse, Robert; Sala, Angelo; Haeggström, Jesper Z; Levy, Bruce D; Filep, János G; Wolkenhauer, Olaf.
Afiliación
  • Serhan CN; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
  • Gupta SK; Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.
  • Perretti M; The William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
  • Godson C; Diabetes Complications Research Centre, Conway Institute & School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland.
  • Brennan E; Diabetes Complications Research Centre, Conway Institute & School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland.
  • Li Y; Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, 400030, China.
  • Soehnlein O; Department of Physiology and Pharmacology (FyFA), Karolinska Institutet, 17177, Stockholm, Sweden; German Center for Cardiovascular Research (DZHK), München, Germany; Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian University, 80336, München, Germany.
  • Shimizu T; Department of Lipidomics, Graduate School of Medicine, The University of Tokyo, 113-0033 Tokyo, Japan; National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, Japan.
  • Werz O; Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, 07743, Jena, Germany.
  • Chiurchiù V; Institute of Translational Pharmacology, National Research Council, 00133, Rome, Italy; Laboratory of Resolution of Neuroinflammation, IRCCS Santa Lucia Foundation, 00143, Rome, Italy.
  • Azzi A; School of Graduate Biomedical Pharmacology and Drug Development Program at Tufts University, Boston, MA 02111, USA.
  • Dubourdeau M; Ambiotis, Canal Biotech 2 - 3 Rue des Satellites, 31400, Toulouse, France.
  • Gupta SS; Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.
  • Schopohl P; Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.
  • Hoch M; Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.
  • Gjorgevikj D; Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.
  • Khan FM; Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.
  • Brauer D; Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany.
  • Tripathi A; CSIR - Indian Institute of Toxicology Research, 226001, Lucknow, India.
  • Cesnulevicius K; Department of Medical Affairs & Research, Heel GmbH, 76532, Baden-Baden, Germany.
  • Lescheid D; Department of Medical Affairs & Research, Heel GmbH, 76532, Baden-Baden, Germany.
  • Schultz M; Department of Medical Affairs & Research, Heel GmbH, 76532, Baden-Baden, Germany.
  • Särndahl E; iRiSC - Inflammatory Response and Infection Susceptibility Centre, Faculty of Medicine and Health, Örebro University, SE-701 82, Örebro, Sweden; School of Medical Sciences, Örebro University, SE-701 82, Örebro, Sweden.
  • Repsilber D; School of Medical Sciences, Örebro University, SE-701 82, Örebro, Sweden.
  • Kruse R; iRiSC - Inflammatory Response and Infection Susceptibility Centre, Faculty of Medicine and Health, Örebro University, SE-701 82, Örebro, Sweden; Department of Clinical Research Laboratory, Faculty of Medicine and Health, Örebro University, SE-701 82, Örebro, Sweden.
  • Sala A; Department of Pharmaceutical Sciences, University of Milan, 20133 Milano, and IRIB, C.N.R, 90146, Palermo, Italy.
  • Haeggström JZ; Department of Medical Biochemistry and Biophysics, Karolinska Institute, SE-171 77, Stockholm, Sweden.
  • Levy BD; Brigham and Women's Hospital, Department of Medicine, Pulmonary and Critical Care Medicine and Harvard Medical School, Boston, MA, 02115, USA.
  • Filep JG; Department of Pathology and Cell Biology, University of Montreal, and Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, H1T 2M4, Canada.
  • Wolkenhauer O; Department of Systems Biology and Bioinformatics, University of Rostock, 18051, Rostock, Germany; Stellenbosch Institute for Advanced Study (STIAS), Wallenberg Research Centre at Stellenbosch University, Stellenbosch, South Africa. Electronic address: olaf.wolkenhauer@uni-rostock.de.
Mol Aspects Med ; 74: 100894, 2020 08.
Article en En | MEDLINE | ID: mdl-32893032
ABSTRACT
Acute inflammation is a protective reaction by the immune system in response to invading pathogens or tissue damage. Ideally, the response should be localized, self-limited, and returning to homeostasis. If not resolved, acute inflammation can result in organ pathologies leading to chronic inflammatory phenotypes. Acute inflammation and inflammation resolution are complex coordinated processes, involving a number of cell types, interacting in space and time. The biomolecular complexity and the fact that several biomedical fields are involved, make a multi- and interdisciplinary approach necessary. The Atlas of Inflammation Resolution (AIR) is a web-based resource capturing an essential part of the state-of-the-art in acute inflammation and inflammation resolution research. The AIR provides an interface for users to search thousands of interactions, arranged in inter-connected multi-layers of process diagrams, covering a wide range of clinically relevant phenotypes. By mapping experimental data onto the AIR, it can be used to elucidate drug action as well as molecular mechanisms underlying different disease phenotypes. For the visualization and exploration of information, the AIR uses the Minerva platform, which is a well-established tool for the presentation of disease maps. The molecular details of the AIR are encoded using international standards. The AIR was created as a freely accessible resource, supporting research and education in the fields of acute inflammation and inflammation resolution. The AIR connects research communities, facilitates clinical decision making, and supports research scientists in the formulation and validation of hypotheses. The AIR is accessible through https//air.bio.informatik.uni-rostock.de.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mediadores de Inflamación / Inflamación Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Mol Aspects Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mediadores de Inflamación / Inflamación Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Mol Aspects Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
...